KOTRA Supports Entry into Japanese Medical Device Market: "Understanding Licensing System and Local Characteristics Is Crucial"
Disseminating Essential Export Know-How
Accelerating Digital Transformation in Healthcare
High Import Dependence Presents Opportunities
As Japan undergoes digital transformation in its healthcare system and continues to rely heavily on imports, interest among domestic medical device companies in entering the Japanese market is rising. In response, a seminar was held to support Korean medical device companies seeking to expand into Japan.
The Korea Trade-Investment Promotion Agency (KOTRA) hosted the "Online Seminar on Entering the Japanese Medical Device Market" on December 5, providing essential practical information for exporting digital medical devices to Japan. The seminar offered guidance on key preparations for entering the local market, such as licensing, customs clearance, and distribution regulations. It also introduced exhibitions and consultation events scheduled for 2026 to support Korean companies' entry into the Japanese market.
Japan entered a super-aged society before Korea and is now facing both a shortage of medical professionals and aging infrastructure. As a result, the Japanese government is actively promoting digital transformation (DX) in the healthcare sector. In June 2023, under the leadership of the Prime Minister's Office and the Digital Agency, Japan established the "Healthcare DX Promotion Headquarters" to set policy directions for digital transformation. Since 2020, the number of new approvals for digital medical devices and their inclusion in health insurance coverage has increased, fueling rapid growth in the digital medical device market.
At the 'Global Medical Device Export Consultation' held at COEX in March this year, Osaka K-Bio Desk is providing certification consulting for participating medical device companies. KOTRA.
View original imageThe Japanese medical device market has steadily grown at an average annual rate of 4%, expanding from 3.9 trillion yen (approximately 3.9 trillion won) in 2019 to 4.5 trillion yen (about 4.3 trillion won) in 2023. In particular, the Med-tech market, which includes medical devices and related solutions incorporating advanced technologies such as artificial intelligence (AI), augmented reality (VR), and 5G (fifth-generation mobile technology), is expected to grow eightfold between 2022 and 2028.
As the integration of digital and AI technologies (DX and AX) in healthcare accelerates, Korean medical device companies with advanced technologies are showing greater interest in entering the Japanese market. However, KOTRA noted that Japan is known for its stringent Pharmaceutical and Medical Device Act (PMD Act), which enforces strict medical device licensing procedures, varying import and customs regulations depending on product type, and a uniquely complex distribution structure. Companies hoping to enter the Japanese market must be well-versed in these requirements.
This seminar focused on providing essential practical information for market entry, including opportunities, licensing under the PMD Act, export customs clearance, medical device distribution regulations, and market structure. Yoon Sangjin, CEO of Medical Bridge, who spoke at the event, stated, "The Japanese medical device market has a high dependence on imports and is proactive in adopting advanced foreign technologies, making it attractive for Korean companies."
In fact, Japan's medical device market is the fourth largest in the world, yet 60-70% of domestic medical device demand is met through imports. More than 60% of new approvals and insurance registrations for advanced medical devices in Japan are granted to foreign companies.
KOTRA operates seven "K-Bio Desks" in locations such as Osaka and New York, expanding consulting services for medical device exports and supporting participation in local exhibitions in key countries. For example, the Osaka Trade Office operated a Korean Pavilion at the 2025 Osaka Medical Device Exhibition and organized export consultation meetings in conjunction with the Osaka-Kansai Expo. In March next year, KOTRA plans to host the "Global Medical Device Export Consultation (GMEP)" by inviting 150 overseas buyers from countries including Japan and the United States, in connection with Korea's largest medical device exhibition, the Korea International Medical & Hospital Equipment Show (KIMES).
G Company, a manufacturer of oral cameras supported by the Osaka Trade Office, successfully obtained local licenses and signed an exclusive sales contract with a Japanese dental buyer for 2025. Japanese Buyer A, who participated in this year's export consultation, advised, "To succeed in the Japanese market, it is crucial to understand the licensing system at the entry stage and develop strategies tailored to the unique characteristics of the Japanese market."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Kim Kyungmi, Director of KOTRA's Osaka Trade Office, stated, "Osaka and Kansai are home to Japan's leading advanced medical industry clusters, providing favorable conditions for Korean companies to enter the Japanese market. In addition to this seminar, we will actively support Korean medical device companies' entry into Japan through exhibitions, export consultations, and various other initiatives."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.